Jennifer Ibrahim

443 total citations
10 papers, 121 citations indexed

About

Jennifer Ibrahim is a scholar working on Physiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Jennifer Ibrahim has authored 10 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 3 papers in Organic Chemistry and 3 papers in Molecular Biology. Recurrent topics in Jennifer Ibrahim's work include Lysosomal Storage Disorders Research (8 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Trypanosoma species research and implications (3 papers). Jennifer Ibrahim is often cited by papers focused on Lysosomal Storage Disorders Research (8 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Trypanosoma species research and implications (3 papers). Jennifer Ibrahim collaborates with scholars based in United States. Jennifer Ibrahim's co-authors include Michel Peterschmitt, Lisa H. Underhill, Sebastiaan J.M. Gaemers, Gerald F. Cox, James A. MacDougall, Andrew J. Carroll, S. Lane Rutledge, Nathaniel H. Robin, Rachel D. Burnside and Fady M. Mikhail and has published in prestigious journals such as Fertility and Sterility, Genetics in Medicine and Molecular Genetics and Metabolism.

In The Last Decade

Jennifer Ibrahim

10 papers receiving 119 citations

Peers

Jennifer Ibrahim
Jeff Castelli United States
Eszter Karg Hungary
Ivan Doykov United Kingdom
Yu-Yuan Ke Taiwan
Evan Katz United States
Jennifer Ibrahim
Citations per year, relative to Jennifer Ibrahim Jennifer Ibrahim (= 1×) peers Shu-Min Kao

Countries citing papers authored by Jennifer Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Jennifer Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Ibrahim more than expected).

Fields of papers citing papers by Jennifer Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Ibrahim. The network helps show where Jennifer Ibrahim may publish in the future.

Co-authorship network of co-authors of Jennifer Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Ibrahim. A scholar is included among the top collaborators of Jennifer Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Ibrahim. Jennifer Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cox, Gerald F., et al.. (2020). Effects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1. Molecular Genetics and Metabolism Reports. 22. 100552–100552. 6 indexed citations
2.
Thibault, Nathan, Jennifer Ibrahim, Michel Peterschmitt, et al.. (2020). Effect of eliglustat on the pharmacokinetics of digoxin, metoprolol, and oral contraceptives and absorption of eliglustat when coadministered with acid-reducing agents. Molecular Genetics and Metabolism. 129(4). 278–285. 5 indexed citations
3.
Peterschmitt, Michel, Gerald F. Cox, Jennifer Ibrahim, et al.. (2017). A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration. Blood Cells Molecules and Diseases. 68. 185–191. 36 indexed citations
4.
Peterschmitt, Michel, et al.. (2017). Two-year postmarketing safety experience with oral eliglustat in adults with type 1 Gaucher disease. Molecular Genetics and Metabolism. 120(1-2). S67–S67. 2 indexed citations
5.
Ibrahim, Jennifer, Lisa H. Underhill, John S. Taylor, Jennifer Angell, & Michel Peterschmitt. (2016). Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry. Molecular Genetics and Metabolism Reports. 8. 17–19. 12 indexed citations
6.
Lau, Heather, Jennifer Ibrahim, Michel Peterschmitt, & Leorah Ross. (2015). Tremor and peripheral neuropathy are infrequent and non-serious events in Gaucher type 1 patients treated with eliglustat. Molecular Genetics and Metabolism. 114(2). S69–S70. 4 indexed citations
7.
Peterschmitt, Michel, John S. Taylor, Jennifer Angell, & Jennifer Ibrahim. (2015). Clinical response to eliglustat in treatment-naive patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase in a real-world setting. Molecular Genetics and Metabolism. 114(2). S93–S93. 2 indexed citations
8.
Mikhail, Fady M., Rachel D. Burnside, Jennifer Ibrahim, et al.. (2013). The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: a proposed categorization system. Genetics in Medicine. 16(1). 92–100. 34 indexed citations
9.
Garibaldi, Luigi, et al.. (2006). Transient Neonatal Hyperparathyroidism: A Presenting Feature of Mucolipidosis Type II. Journal of Pediatric Endocrinology and Metabolism. 19(6). 859–62. 9 indexed citations
10.
Hagen, Stanley Von, et al.. (1994). Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome. Fertility and Sterility. 61(6). 1027–1033. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026